Triple

T19992841
Position Surface form Disambiguated ID Type / Status
Subject NMDA receptor E494104 entity
Predicate pharmacologicallyBlockedBy P58407 FINISHED
Object MK-801 NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: MK-801 | Statement: [NMDA receptor, pharmacologicallyBlockedBy, MK-801]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: MK-801
Context triple: [NMDA receptor, pharmacologicallyBlockedBy, MK-801]
  • A. Namenda
    Namenda is a prescription medication used to treat moderate to severe Alzheimer's disease by regulating the activity of glutamate in the brain.
  • B. Risperdal
    Risperdal is the brand name for risperidone, an atypical antipsychotic medication commonly prescribed to treat schizophrenia, bipolar disorder, and irritability associated with autism.
  • C. pimozide
    Pimozide is a typical antipsychotic medication primarily used to treat Tourette’s disorder and severe tics.
  • D. Aptidon
    Aptidon is the surname of Hassan Gouled Aptidon, the first president of the Republic of Djibouti.
  • E. thioridazine
    Thioridazine is an older antipsychotic medication from the phenothiazine class, primarily used in the past to treat schizophrenia but now rarely prescribed due to its risk of serious heart rhythm disturbances.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: MK-801
Target entity description: MK-801 (dizocilpine) is a potent noncompetitive NMDA receptor antagonist widely used in research to study glutamatergic neurotransmission and neurotoxicity.
  • A. Namenda
    Namenda is a prescription medication used to treat moderate to severe Alzheimer's disease by regulating the activity of glutamate in the brain.
  • B. Risperdal
    Risperdal is the brand name for risperidone, an atypical antipsychotic medication commonly prescribed to treat schizophrenia, bipolar disorder, and irritability associated with autism.
  • C. pimozide
    Pimozide is a typical antipsychotic medication primarily used to treat Tourette’s disorder and severe tics.
  • D. Aptidon
    Aptidon is the surname of Hassan Gouled Aptidon, the first president of the Republic of Djibouti.
  • E. thioridazine
    Thioridazine is an older antipsychotic medication from the phenothiazine class, primarily used in the past to treat schizophrenia but now rarely prescribed due to its risk of serious heart rhythm disturbances.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69da626a67648190af9653832a3aeced completed April 11, 2026, 3:02 p.m.
NER Named-entity recognition batch_69e65fe2036c8190b9f313215ad44e87 completed April 20, 2026, 5:18 p.m.
Created at: April 11, 2026, 3:31 p.m.